NHS under pressure to provide new breast cancer drugs
13th Dec 2005, 01:48 GMT
The National Health Service in the UK is being put under considerable pressure by Cancer charities to widen access to a promising new class of breast cancer drug as new evidence suggests the latest treatment is far superior to Tamoxifen, the long established premier drug for women with the early stage of the disease.
NHS under pressure to provide new breast cancer drugs related news:
- Breast cancer drugs may slow growth of lung cancer — EurekAlert! - Breaking News
- Gene variation affects tamoxifen's benefit for breast cancer — EurekAlert! - Cancer
- 'I just got breast cancer.' — Breast Cancer Chronicles
- Survival Benefit For Arimidex™ In Early Breast Cancer — Medical News Today RSS/XML Feed
- Mayo Clinic reports tamoxifen benefit for breast-cancer patients tied to inherited gene — EurekAlert! - Cancer
- Exercise can help with cancer — The Cancer Blog
- Gene effects benefit of breast-cancer drug — KeralaNext: Health
- Two Types Of Breast Cancer Treatments Show Similar Benefit — ScienceDaily Headlines: Health & Medicine
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- More good news - Femara helps prevent the return of breast cancer — News-Medical News Feed
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info